NEW YORK ─ Advanced Biological Laboratories said on Monday that it has received CE-IVD marking for its UltraGene Combo2Screen SARS-CoV-2 qPCR assay, enabling its use in the European Union and other countries that accept the designation.
The Luxembourg-based firm said the qPCR detection kit has been validated with SARS-CoV-2 RNA extracted from nasopharyngeal swabs and saliva.